Stage 2 | Stage 3 | Total | ||
Survey 1 | Survey 2 | Survey 3, HPP | ||
Invited REPEM members | 69 | 69 | 69 | 69 |
Austria | 1 | 1 | 1 | 1 |
Belgium | 1 | 1 | 1 | |
France | 4 | 1 | 3 | 4 |
Germany | 1 | 1 | 1 | |
Hungary | 2 | 1 | 2 | 3 |
Israel | 1 | 2 | 1 | 2 |
Italy | 5 | 4 | 2 | 6 |
Latvia | 1 | 1 | 1 | 1 |
Lithuania | 1 | 1 | ||
Malta | 1 | 1 | ||
The Netherlands | 3 | 3 | 1 | 3 |
Portugal | 1 | 1 | 1 | |
Spain | 6 | 6 | 5 | 7 |
Sweden | 2 | 2 | ||
Switzerland | 6 | 3 | 5 | 7 |
Turkey | 4 | 5 | 3 | 6 |
UK | 3 | 2 | 3 | 4 |
All | 39 (57%) | 35 (51%) | 28 (41%) | 52 (75%) |
HPP, Hanlon prioritisation process; REPEM, Research in European Paediatric Emergency Medicine.